Lantheus Holdings (LNTH) Net Cash Flow (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Net Cash Flow of $139.5 million for Q1 2026, up 444.33% year-over-year from $25.6 million in Q1 2025, and up 730.66% quarter-over-quarter from -$22.1 million in Q4 2025.
Lantheus Holdings (LNTH) Net Cash Flow (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Net Cash Flow for 13 consecutive years, with $139.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow rose 444.33% year-over-year to $139.5 million; the TTM figure through Mar 2026 stood at -$439.7 million (down 298.12% YoY), while the FY2025 annual figure was -$553.6 million, down 376.53% from the prior year.
- Net Cash Flow advanced to $139.5 million in Q1 2026 per LNTH's latest filing, from -$22.1 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $200.1 million in Q3 2023 and bottomed at -$313.3 million in Q3 2025.
- Historically, Net Cash Flow has averaged $23.6 million across 5 years, with a median of $47.5 million in 2024.
- Annual changes were most pronounced in 2022 — Net Cash Flow jumped 43981.96% — and 2025, when it plunged 713.54%.
- Lantheus Holdings' Net Cash Flow stood at $158.5 million in 2022, then sank by 37.04% to $99.8 million in 2023, then sank by 52.42% to $47.5 million in 2024, then sank by 146.59% to -$22.1 million in 2025, then surged by 730.66% to $139.5 million in 2026.
- Business Quant data shows LNTH's Net Cash Flow at $139.5 million in Q1 2026, -$22.1 million in Q4 2025, and -$313.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 94.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 94.69 Mn |
| Jun 30, 2026 | 94.69 Mn |
| Mar 31, 2026 | 139.49 Mn |
| Mar 31, 2026 | 139.49 Mn |
| Dec 31, 2025 | -22.12 Mn |
| Dec 31, 2025 | -22.12 Mn |
| Sep 30, 2025 | -313.34 Mn |
| Sep 30, 2025 | -313.34 Mn |
| Jun 30, 2025 | -243.78 Mn |
| Jun 30, 2025 | -243.78 Mn |
| Mar 31, 2025 | 25.63 Mn |
| Mar 31, 2025 | 25.63 Mn |
| Dec 31, 2024 | 47.47 Mn |
| Dec 31, 2024 | 47.47 Mn |
| Sep 30, 2024 | 109.13 Mn |
| Sep 30, 2024 | 109.13 Mn |
| Jun 30, 2024 | 39.73 Mn |
| Jun 30, 2024 | 39.73 Mn |
| Mar 31, 2024 | 3.86 Mn |
| Mar 31, 2024 | 3.86 Mn |